Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.



    
    Ontario biotech companies work together on innovative bone protein
    technology
    

    TORONTO, Oct. 28 /CNW/ - Thomas Wellner, President and CEO of Therapure
BioPharma Inc. and Dr. Cameron Clokie, President and CEO of Induce Biologics
Inc. today announced a development partnership utilizing an innovative
approach to the production and manufacture of selected growth factors for
stimulating bone regeneration. Such growth factors are critical tools used in
regenerative medicine, with particular applications in the regeneration of the
skeleton.
    Therapure will apply its experience and knowledge in cell culture and in
the design and development of scaled-up biologic manufacturing processes to
advance the initial research and development conducted by Induce. The
technology is a result of over 10 years of research and development by the
founders of Induce in the areas of bone regeneration and the development of
growth factor containing bone grafts.
    "Induce's technology is a tremendous example of the creativity and
innovation that exists in Ontario," said Thomas Wellner. "We are very pleased
that they have chosen Therapure Biopharma as their partner for the further
development of this important new technology and we look forward to working
with them to bring this product to a global market."
    "Our technology was invented in Canada", said Cameron Clokie, "and we are
excited to have found a company in Ontario that is capable of working with us
to further develop this technology. We are pleased that Therapure Biopharma is
as eager as we are to make this technology available to patients world-wide."

    About Therapure Biopharma:

    Therapure Biopharma Inc. is an integrated biopharmaceutical company that
develops, manufactures, purifies, and packages therapeutic proteins. Therapure
Biopharma acquired its Canadian-built and conceived facility from Hemosol
Corporation, a specialist in therapies derived from hemoglobin, a blood
protein. Therapure Biopharma applies scientific, manufacturing, and downstream
purification expertise with an intimate understanding of advanced biology,
complex proteins, and regulatory processes to develop effective and innovative
solutions to advance products from discovery to market.
    For more information, please visit: www.therapurebio.com

    About Induce Biologics Inc.:

    Induce Biologics Inc was founded in 2008 to develop and commercialize
technologies invented at the University of Toronto. Induce Biologics' goal is
to utilize these technologies along with others being developed internally to
create cost effective growth factor containing bone grafts for mammalian
skeletal regeneration.





For further information:

For further information: Media Contact: Thomas Wellner, President and
CEO, Therapure Biopharma Inc., (905) 286-6204, ceo@therapurebio.com

Organization Profile

THERAPURE BIOPHARMA INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890